On December 17, 2025, the Ministry of Health published two draft HTA reports developed within the National HTA Program for Medical Devices and launched a public consultation. Reports concern continuous glucose monitoring and the treatment of benign prostatic hyperplasia. Comments can be submitted until January 16, 2026.
On October 14, 2025, the National Agency for Regional Health Services (AGENAS) published the list of technologies prioritized for evaluation within the National HTA Program for Medical Devices in 2025. Technologies from the fields of endocrinology, men’s health, neurology/neurosurgery, and radiotherapy have been identified as priorities and are currently undergoing health technology assessment.
On July 15, 2025, the Austrian Institute for HTA (AIHTA) published four new HTAs (decision support documents) and two updates to previous decision support documents that provide recommendations regarding possible inclusion of new procedures in the reimbursement catalog of individual medical services (MEL). The assessments concerned cardiovascular, gastrointestinal, interventional radiology, men's health, urology, and orthopedics fields.
